Global Drug Eluting Stents (DES) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Apr, 2020
|
Report ID: 132040
|
127
|
Medical Devices
Market Overview
The global Drug Eluting Stents (DES) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drug Eluting Stents (DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drug Eluting Stents (DES) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Eluting Stents (DES) market has been segmented into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
By Application, Drug Eluting Stents (DES) has been segmented into:
Coronary Heart Disease
Clinical
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Eluting Stents (DES) market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Eluting Stents (DES) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Eluting Stents (DES) market.
The report offers in-depth assessment of the growth and other aspects of the Drug Eluting Stents (DES) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Eluting Stents (DES) Market Share Analysis
Drug Eluting Stents (DES) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Eluting Stents (DES) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Eluting Stents (DES) sales, revenue and market share for each player covered in this report.
The major players covered in Drug Eluting Stents (DES) are:
Abbott Vascular
DISA Vascular
Biosensors
Advantec Vascular
Boston Scientific
B.Braun Melsengen AG
Medtronic Vascular
Blue Medical
Biotronik
Essen
Relisys Medical
Sino Medical
MicroPort Medical
Terumo Medical
Reva Medical
Promed Medical
MIV Therapeutics
Sorin
Sahajanand
Orbusneich
Among other players domestic and global, Drug Eluting Stents (DES) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Stents (DES) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Eluting Stents (DES), with price, sales, revenue and global market share of Drug Eluting Stents (DES) in 2018 and 2019.
Chapter 3, the Drug Eluting Stents (DES) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Stents (DES) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drug Eluting Stents (DES) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drug Eluting Stents (DES) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The global Drug Eluting Stents (DES) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drug Eluting Stents (DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drug Eluting Stents (DES) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Eluting Stents (DES) market has been segmented into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
By Application, Drug Eluting Stents (DES) has been segmented into:
Coronary Heart Disease
Clinical
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Eluting Stents (DES) market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Eluting Stents (DES) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Eluting Stents (DES) market.
The report offers in-depth assessment of the growth and other aspects of the Drug Eluting Stents (DES) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Eluting Stents (DES) Market Share Analysis
Drug Eluting Stents (DES) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Eluting Stents (DES) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Eluting Stents (DES) sales, revenue and market share for each player covered in this report.
The major players covered in Drug Eluting Stents (DES) are:
Abbott Vascular
DISA Vascular
Biosensors
Advantec Vascular
Boston Scientific
B.Braun Melsengen AG
Medtronic Vascular
Blue Medical
Biotronik
Essen
Relisys Medical
Sino Medical
MicroPort Medical
Terumo Medical
Reva Medical
Promed Medical
MIV Therapeutics
Sorin
Sahajanand
Orbusneich
Among other players domestic and global, Drug Eluting Stents (DES) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Stents (DES) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Eluting Stents (DES), with price, sales, revenue and global market share of Drug Eluting Stents (DES) in 2018 and 2019.
Chapter 3, the Drug Eluting Stents (DES) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Stents (DES) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drug Eluting Stents (DES) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drug Eluting Stents (DES) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Drug Eluting Stents (DES) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Eluting Stents (DES) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cobalt-chromium alloy Stents
1.2.3 Magnesium alloy Stents
1.2.4 Tyrosine polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum chromium alloy Stents
1.2.7 Stainless steel Stents
1.2.8 Other Materials
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Eluting Stents (DES) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Overview of Global Drug Eluting Stents (DES) Market
1.4.1 Global Drug Eluting Stents (DES) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East& Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Vascular
2.1.1 Abbott Vascular Details
2.1.2 Abbott Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Vascular SWOT Analysis
2.1.4 Abbott Vascular Product and Services
2.1.5 Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DISA Vascular
2.2.1 DISA Vascular Details
2.2.2 DISA Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DISA Vascular SWOT Analysis
2.2.4 DISA Vascular Product and Services
2.2.5 DISA Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biosensors
2.3.1 Biosensors Details
2.3.2 Biosensors Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biosensors SWOT Analysis
2.3.4 Biosensors Product and Services
2.3.5 Biosensors Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advantec Vascular
2.4.1 Advantec Vascular Details
2.4.2 Advantec Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advantec Vascular SWOT Analysis
2.4.4 Advantec Vascular Product and Services
2.4.5 Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boston Scientific SWOT Analysis
2.5.4 Boston Scientific Product and Services
2.5.5 Boston Scientific Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 B.Braun Melsengen AG
2.6.1 B.Braun Melsengen AG Details
2.6.2 B.Braun Melsengen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 B.Braun Melsengen AG SWOT Analysis
2.6.4 B.Braun Melsengen AG Product and Services
2.6.5 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medtronic Vascular
2.7.1 Medtronic Vascular Details
2.7.2 Medtronic Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Medtronic Vascular SWOT Analysis
2.7.4 Medtronic Vascular Product and Services
2.7.5 Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Blue Medical
2.8.1 Blue Medical Details
2.8.2 Blue Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Blue Medical SWOT Analysis
2.8.4 Blue Medical Product and Services
2.8.5 Blue Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biotronik
2.9.1 Biotronik Details
2.9.2 Biotronik Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biotronik SWOT Analysis
2.9.4 Biotronik Product and Services
2.9.5 Biotronik Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Essen
2.10.1 Essen Details
2.10.2 Essen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Essen SWOT Analysis
2.10.4 Essen Product and Services
2.10.5 Essen Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Relisys Medical
2.11.1 Relisys Medical Details
2.11.2 Relisys Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Relisys Medical SWOT Analysis
2.11.4 Relisys Medical Product and Services
2.11.5 Relisys Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sino Medical
2.12.1 Sino Medical Details
2.12.2 Sino Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sino Medical SWOT Analysis
2.12.4 Sino Medical Product and Services
2.12.5 Sino Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MicroPort Medical
2.13.1 MicroPort Medical Details
2.13.2 MicroPort Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MicroPort Medical SWOT Analysis
2.13.4 MicroPort Medical Product and Services
2.13.5 MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Terumo Medical
2.14.1 Terumo Medical Details
2.14.2 Terumo Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Terumo Medical SWOT Analysis
2.14.4 Terumo Medical Product and Services
2.14.5 Terumo Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Reva Medical
2.15.1 Reva Medical Details
2.15.2 Reva Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Reva Medical SWOT Analysis
2.15.4 Reva Medical Product and Services
2.15.5 Reva Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Promed Medical
2.16.1 Promed Medical Details
2.16.2 Promed Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Promed Medical SWOT Analysis
2.16.4 Promed Medical Product and Services
2.16.5 Promed Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 MIV Therapeutics
2.17.1 MIV Therapeutics Details
2.17.2 MIV Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 MIV Therapeutics SWOT Analysis
2.17.4 MIV Therapeutics Product and Services
2.17.5 MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Sorin
2.18.1 Sorin Details
2.18.2 Sorin Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Sorin SWOT Analysis
2.18.4 Sorin Product and Services
2.18.5 Sorin Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sahajanand
2.19.1 Sahajanand Details
2.19.2 Sahajanand Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sahajanand SWOT Analysis
2.19.4 Sahajanand Product and Services
2.19.5 Sahajanand Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Orbusneich
2.20.1 Orbusneich Details
2.20.2 Orbusneich Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Orbusneich SWOT Analysis
2.20.4 Orbusneich Product and Services
2.20.5 Orbusneich Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drug Eluting Stents (DES) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drug Eluting Stents (DES) Manufacturer Market Share in 2019
3.3.2 Top 6 Drug Eluting Stents (DES) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drug Eluting Stents (DES) Sales, Revenue and Market Share by Regions
4.1.1 Global Drug Eluting Stents (DES) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Regions (2015-2020)
4.2 North America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.3 Europe Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.5 South America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
5.1.1 North America Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
5.1.2 North America Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
5.2 United States Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5.3 Canada Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5.4 Mexico Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
6.1.1 Europe Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
6.2 Germany Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.3 UK Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.4 France Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.5 Russia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.6 Italy Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drug Eluting Stents (DES) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drug Eluting Stents (DES) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Market Share by Regions (2015-2020)
7.2 China Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.3 Japan Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.4 Korea Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.5 India Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.7 Australia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
8.1.1 South America Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
8.1.2 South America Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
8.3 Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9 Middle East& Africa by Countries
9.1 Middle East& Africa Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
9.1.1 Middle East& Africa Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East& Africa Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.3 Turkey Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.4 Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.5 South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drug Eluting Stents (DES) Sales and Market Share by Type (2015-2020)
10.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Type (2015-2020)
10.3 Global Drug Eluting Stents (DES) Price by Type (2015-2020)
11 Global Drug Eluting Stents (DES) Market Segment by Application
11.1 Global Drug Eluting Stents (DES) Sales Market Share by Application (2015-2020)
11.2 Global Drug Eluting Stents (DES) Revenue Market Share by Application (2015-2020)
11.3 Global Drug Eluting Stents (DES) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drug Eluting Stents (DES) Sales, Revenue and Growth Rate (2021-2025)
12.2 Drug Eluting Stents (DES) Market Forecast by Regions (2021-2025)
12.2.1 North America Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.2 Europe Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.4 South America Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.5 Middle East& Africa Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.3 Drug Eluting Stents (DES) Market Forecast by Type (2021-2025)
12.3.1 Global Drug Eluting Stents (DES) Sales Forecast by Type (2021-2025)
12.3.2 Global Drug Eluting Stents (DES) Market Share Forecast by Type (2021-2025)
12.4 Drug Eluting Stents (DES) Market Forecast by Application (2021-2025)
12.4.1 Global Drug Eluting Stents (DES) Sales Forecast by Application (2021-2025)
12.4.2 Global Drug Eluting Stents (DES) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
1 Market Overview
1.1 Drug Eluting Stents (DES) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Eluting Stents (DES) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cobalt-chromium alloy Stents
1.2.3 Magnesium alloy Stents
1.2.4 Tyrosine polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum chromium alloy Stents
1.2.7 Stainless steel Stents
1.2.8 Other Materials
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Eluting Stents (DES) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Overview of Global Drug Eluting Stents (DES) Market
1.4.1 Global Drug Eluting Stents (DES) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East& Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Vascular
2.1.1 Abbott Vascular Details
2.1.2 Abbott Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Vascular SWOT Analysis
2.1.4 Abbott Vascular Product and Services
2.1.5 Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DISA Vascular
2.2.1 DISA Vascular Details
2.2.2 DISA Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DISA Vascular SWOT Analysis
2.2.4 DISA Vascular Product and Services
2.2.5 DISA Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biosensors
2.3.1 Biosensors Details
2.3.2 Biosensors Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biosensors SWOT Analysis
2.3.4 Biosensors Product and Services
2.3.5 Biosensors Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advantec Vascular
2.4.1 Advantec Vascular Details
2.4.2 Advantec Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advantec Vascular SWOT Analysis
2.4.4 Advantec Vascular Product and Services
2.4.5 Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boston Scientific SWOT Analysis
2.5.4 Boston Scientific Product and Services
2.5.5 Boston Scientific Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 B.Braun Melsengen AG
2.6.1 B.Braun Melsengen AG Details
2.6.2 B.Braun Melsengen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 B.Braun Melsengen AG SWOT Analysis
2.6.4 B.Braun Melsengen AG Product and Services
2.6.5 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medtronic Vascular
2.7.1 Medtronic Vascular Details
2.7.2 Medtronic Vascular Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Medtronic Vascular SWOT Analysis
2.7.4 Medtronic Vascular Product and Services
2.7.5 Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Blue Medical
2.8.1 Blue Medical Details
2.8.2 Blue Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Blue Medical SWOT Analysis
2.8.4 Blue Medical Product and Services
2.8.5 Blue Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biotronik
2.9.1 Biotronik Details
2.9.2 Biotronik Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biotronik SWOT Analysis
2.9.4 Biotronik Product and Services
2.9.5 Biotronik Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Essen
2.10.1 Essen Details
2.10.2 Essen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Essen SWOT Analysis
2.10.4 Essen Product and Services
2.10.5 Essen Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Relisys Medical
2.11.1 Relisys Medical Details
2.11.2 Relisys Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Relisys Medical SWOT Analysis
2.11.4 Relisys Medical Product and Services
2.11.5 Relisys Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sino Medical
2.12.1 Sino Medical Details
2.12.2 Sino Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sino Medical SWOT Analysis
2.12.4 Sino Medical Product and Services
2.12.5 Sino Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MicroPort Medical
2.13.1 MicroPort Medical Details
2.13.2 MicroPort Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MicroPort Medical SWOT Analysis
2.13.4 MicroPort Medical Product and Services
2.13.5 MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Terumo Medical
2.14.1 Terumo Medical Details
2.14.2 Terumo Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Terumo Medical SWOT Analysis
2.14.4 Terumo Medical Product and Services
2.14.5 Terumo Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Reva Medical
2.15.1 Reva Medical Details
2.15.2 Reva Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Reva Medical SWOT Analysis
2.15.4 Reva Medical Product and Services
2.15.5 Reva Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Promed Medical
2.16.1 Promed Medical Details
2.16.2 Promed Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Promed Medical SWOT Analysis
2.16.4 Promed Medical Product and Services
2.16.5 Promed Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 MIV Therapeutics
2.17.1 MIV Therapeutics Details
2.17.2 MIV Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 MIV Therapeutics SWOT Analysis
2.17.4 MIV Therapeutics Product and Services
2.17.5 MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Sorin
2.18.1 Sorin Details
2.18.2 Sorin Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Sorin SWOT Analysis
2.18.4 Sorin Product and Services
2.18.5 Sorin Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sahajanand
2.19.1 Sahajanand Details
2.19.2 Sahajanand Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sahajanand SWOT Analysis
2.19.4 Sahajanand Product and Services
2.19.5 Sahajanand Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Orbusneich
2.20.1 Orbusneich Details
2.20.2 Orbusneich Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Orbusneich SWOT Analysis
2.20.4 Orbusneich Product and Services
2.20.5 Orbusneich Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drug Eluting Stents (DES) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drug Eluting Stents (DES) Manufacturer Market Share in 2019
3.3.2 Top 6 Drug Eluting Stents (DES) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drug Eluting Stents (DES) Sales, Revenue and Market Share by Regions
4.1.1 Global Drug Eluting Stents (DES) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Regions (2015-2020)
4.2 North America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.3 Europe Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.5 South America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
5.1.1 North America Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
5.1.2 North America Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
5.2 United States Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5.3 Canada Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
5.4 Mexico Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
6.1.1 Europe Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
6.2 Germany Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.3 UK Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.4 France Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.5 Russia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
6.6 Italy Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drug Eluting Stents (DES) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drug Eluting Stents (DES) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Market Share by Regions (2015-2020)
7.2 China Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.3 Japan Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.4 Korea Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.5 India Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
7.7 Australia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
8.1.1 South America Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
8.1.2 South America Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
8.3 Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9 Middle East& Africa by Countries
9.1 Middle East& Africa Drug Eluting Stents (DES) Sales, Revenue and Market Share by Country
9.1.1 Middle East& Africa Drug Eluting Stents (DES) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East& Africa Drug Eluting Stents (DES) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.3 Turkey Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.4 Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
9.5 South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drug Eluting Stents (DES) Sales and Market Share by Type (2015-2020)
10.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Type (2015-2020)
10.3 Global Drug Eluting Stents (DES) Price by Type (2015-2020)
11 Global Drug Eluting Stents (DES) Market Segment by Application
11.1 Global Drug Eluting Stents (DES) Sales Market Share by Application (2015-2020)
11.2 Global Drug Eluting Stents (DES) Revenue Market Share by Application (2015-2020)
11.3 Global Drug Eluting Stents (DES) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drug Eluting Stents (DES) Sales, Revenue and Growth Rate (2021-2025)
12.2 Drug Eluting Stents (DES) Market Forecast by Regions (2021-2025)
12.2.1 North America Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.2 Europe Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.4 South America Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.2.5 Middle East& Africa Drug Eluting Stents (DES) Market Forecast (2021-2025)
12.3 Drug Eluting Stents (DES) Market Forecast by Type (2021-2025)
12.3.1 Global Drug Eluting Stents (DES) Sales Forecast by Type (2021-2025)
12.3.2 Global Drug Eluting Stents (DES) Market Share Forecast by Type (2021-2025)
12.4 Drug Eluting Stents (DES) Market Forecast by Application (2021-2025)
12.4.1 Global Drug Eluting Stents (DES) Sales Forecast by Application (2021-2025)
12.4.2 Global Drug Eluting Stents (DES) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Drug Eluting Stents (DES) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Eluting Stents (DES) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Eluting Stents (DES) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Vascular Drug Eluting Stents (DES) Major Business
Table 9. Abbott Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 10. Abbott Vascular SWOT Analysis
Table 11. Abbott Vascular Drug Eluting Stents (DES) Product and Services
Table 12. Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 14. DISA Vascular Drug Eluting Stents (DES) Major Business
Table 15. DISA Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 16. DISA Vascular SWOT Analysis
Table 17. DISA Vascular Drug Eluting Stents (DES) Product and Services
Table 18. DISA Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biosensors Basic Information, Manufacturing Base and Competitors
Table 20. Biosensors Drug Eluting Stents (DES) Major Business
Table 21. Biosensors Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 22. Biosensors SWOT Analysis
Table 23. Biosensors Drug Eluting Stents (DES) Product and Services
Table 24. Biosensors Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 26. Advantec Vascular Drug Eluting Stents (DES) Major Business
Table 27. Advantec Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 28. Advantec Vascular SWOT Analysis
Table 29. Advantec Vascular Drug Eluting Stents (DES) Product and Services
Table 30. Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 32. Boston Scientific Drug Eluting Stents (DES) Major Business
Table 33. Boston Scientific Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 34. Boston Scientific SWOT Analysis
Table 35. Boston Scientific Drug Eluting Stents (DES) Product and Services
Table 36. Boston Scientific Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 38. B.Braun Melsengen AG Drug Eluting Stents (DES) Major Business
Table 39. B.Braun Melsengen AG Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 40. B.Braun Melsengen AG SWOT Analysis
Table 41. B.Braun Melsengen AG Drug Eluting Stents (DES) Product and Services
Table 42. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Vascular Drug Eluting Stents (DES) Major Business
Table 45. Medtronic Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 46. Medtronic Vascular SWOT Analysis
Table 47. Medtronic Vascular Drug Eluting Stents (DES) Product and Services
Table 48. Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 50. Blue Medical Drug Eluting Stents (DES) Major Business
Table 51. Blue Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 52. Blue Medical SWOT Analysis
Table 53. Blue Medical Drug Eluting Stents (DES) Product and Services
Table 54. Blue Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biotronik Basic Information, Manufacturing Base and Competitors
Table 56. Biotronik Drug Eluting Stents (DES) Major Business
Table 57. Biotronik Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 58. Biotronik SWOT Analysis
Table 59. Biotronik Drug Eluting Stents (DES) Product and Services
Table 60. Biotronik Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Essen Basic Information, Manufacturing Base and Competitors
Table 62. Essen Drug Eluting Stents (DES) Major Business
Table 63. Essen Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 64. Essen SWOT Analysis
Table 65. Essen Drug Eluting Stents (DES) Product and Services
Table 66. Essen Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 68. Relisys Medical Drug Eluting Stents (DES) Major Business
Table 69. Relisys Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 70. Relisys Medical SWOT Analysis
Table 71. Relisys Medical Drug Eluting Stents (DES) Product and Services
Table 72. Relisys Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 74. Sino Medical Drug Eluting Stents (DES) Major Business
Table 75. Sino Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 76. Sino Medical SWOT Analysis
Table 77. Sino Medical Drug Eluting Stents (DES) Product and Services
Table 78. Sino Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 80. MicroPort Medical Drug Eluting Stents (DES) Major Business
Table 81. MicroPort Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 82. MicroPort Medical SWOT Analysis
Table 83. MicroPort Medical Drug Eluting Stents (DES) Product and Services
Table 84. MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 86. Terumo Medical Drug Eluting Stents (DES) Major Business
Table 87. Terumo Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 88. Terumo Medical SWOT Analysis
Table 89. Terumo Medical Drug Eluting Stents (DES) Product and Services
Table 90. Terumo Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 92. Reva Medical Drug Eluting Stents (DES) Major Business
Table 93. Reva Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 94. Reva Medical SWOT Analysis
Table 95. Reva Medical Drug Eluting Stents (DES) Product and Services
Table 96. Reva Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 98. Promed Medical Drug Eluting Stents (DES) Major Business
Table 99. Promed Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 100. Promed Medical SWOT Analysis
Table 101. Promed Medical Drug Eluting Stents (DES) Product and Services
Table 102. Promed Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. MIV Therapeutics Drug Eluting Stents (DES) Major Business
Table 105. MIV Therapeutics Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 106. MIV Therapeutics SWOT Analysis
Table 107. MIV Therapeutics Drug Eluting Stents (DES) Product and Services
Table 108. MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Sorin Drug Eluting Stents (DES) Type and Application
Table 110. Sorin Drug Eluting Stents (DES) Major Business
Table 111. Sorin Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 112. Sorin SWOT Analysis
Table 113. Sorin Drug Eluting Stents (DES) Product and Services
Table 114. Sorin Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 116. Sahajanand Drug Eluting Stents (DES) Major Business
Table 117. Sahajanand Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 118. Sahajanand SWOT Analysis
Table 119. Sahajanand Drug Eluting Stents (DES) Product and Services
Table 120. Sahajanand Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 122. Orbusneich Drug Eluting Stents (DES) Major Business
Table 123. Orbusneich Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 124. Orbusneich SWOT Analysis
Table 125. Orbusneich Drug Eluting Stents (DES) Product and Services
Table 126. Orbusneich Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Drug Eluting Stents (DES) Sales by Manufacturer (2018-2019) (K Units)
Table 128. Global Drug Eluting Stents (DES) Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Drug Eluting Stents (DES) Sales by Regions (2015-2020) (K Units)
Table 130. Global Drug Eluting Stents (DES) Sales Market Share by Regions (2015-2020)
Table 131. Global Drug Eluting Stents (DES) Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 133. North America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 134. North America Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 136. Europe Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 137. Europe Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 138. Europe Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Drug Eluting Stents (DES) Sales by Regions (2015-2020) (K Units)
Table 140. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Drug Eluting Stents (DES) Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 143. South America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 144. South America Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 146. Middle East& Africa Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 147. Middle East& Africa Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 148. Middle East& Africa Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East& Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 150. Global Drug Eluting Stents (DES) Sales by Type (2015-2020) (K Units)
Table 151. Global Drug Eluting Stents (DES) Sales Share by Type (2015-2020)
Table 152. Global Drug Eluting Stents (DES) Revenue by Type (2015-2020) (USD Million)
Table 153. Global Drug Eluting Stents (DES) Revenue Share by Type (2015-2020)
Table 154. Global Drug Eluting Stents (DES) Sales by Application (2015-2020) (K Units)
Table 155. Global Drug Eluting Stents (DES) Sales Share by Application (2015-2020)
Table 156. Global Drug Eluting Stents (DES) Sales Forecast by Regions (2021-2025) (K Units)
Table 157. Global Drug Eluting Stents (DES) Market Share Forecast by Regions (2021-2025)
Table 158. Global Drug Eluting Stents (DES) Sales Forecast by Type (2021-2025) (K Units)
Table 159. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2021-2025)
Table 160. Global Drug Eluting Stents (DES) Sales Forecast by Application (2021-2025)
Table 161. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros& Cons
Table 163. Indirect Channel Pros& Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drug Eluting Stents (DES) Picture
Figure 2. Global Sales Market Share of Drug Eluting Stents (DES) by Type in 2019
Figure 3. Cobalt-chromium alloy Stents Picture
Figure 4. Magnesium alloy Stents Picture
Figure 5. Tyrosine polycarbonate Stents Picture
Figure 6. Nitinol Stents Picture
Figure 7. Platinum chromium alloy Stents Picture
Figure 8. Stainless steel Stents Picture
Figure 9. Other Materials Picture
Figure 10. Drug Eluting Stents (DES) Sales Market Share by Application in 2018
Figure 11. Coronary Heart Disease Picture
Figure 12. Clinical Picture
Figure 13. Global Drug Eluting Stents (DES) Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturer in 2019
Figure 34. Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Drug Eluting Stents (DES) Revenue Market Share by Regions (2015-2020)
Figure 41. Global Drug Eluting Stents (DES) Revenue Market Share by Regions in 2018
Figure 42. North America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 43. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 45. South America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 46. Middle East& Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 47. North America Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Figure 49. North America Drug Eluting Stents (DES) Sales Market Share by Countries in 2018
Figure 50. North America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Drug Eluting Stents (DES) Revenue Market Share by Countries in 2018
Figure 52. United States Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 58. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Drug Eluting Stents (DES) Revenue Market Share by Regions 2019
Figure 66. China Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Drug Eluting Stents (DES) Sales Market Share by Countries in 2019
Figure 73. South America Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 74. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Drug Eluting Stents (DES) Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Drug Eluting Stents (DES) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 90. Middle East& Africa Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Drug Eluting Stents (DES) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Eluting Stents (DES) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Eluting Stents (DES) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Vascular Drug Eluting Stents (DES) Major Business
Table 9. Abbott Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 10. Abbott Vascular SWOT Analysis
Table 11. Abbott Vascular Drug Eluting Stents (DES) Product and Services
Table 12. Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 14. DISA Vascular Drug Eluting Stents (DES) Major Business
Table 15. DISA Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 16. DISA Vascular SWOT Analysis
Table 17. DISA Vascular Drug Eluting Stents (DES) Product and Services
Table 18. DISA Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biosensors Basic Information, Manufacturing Base and Competitors
Table 20. Biosensors Drug Eluting Stents (DES) Major Business
Table 21. Biosensors Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 22. Biosensors SWOT Analysis
Table 23. Biosensors Drug Eluting Stents (DES) Product and Services
Table 24. Biosensors Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 26. Advantec Vascular Drug Eluting Stents (DES) Major Business
Table 27. Advantec Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 28. Advantec Vascular SWOT Analysis
Table 29. Advantec Vascular Drug Eluting Stents (DES) Product and Services
Table 30. Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 32. Boston Scientific Drug Eluting Stents (DES) Major Business
Table 33. Boston Scientific Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 34. Boston Scientific SWOT Analysis
Table 35. Boston Scientific Drug Eluting Stents (DES) Product and Services
Table 36. Boston Scientific Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 38. B.Braun Melsengen AG Drug Eluting Stents (DES) Major Business
Table 39. B.Braun Melsengen AG Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 40. B.Braun Melsengen AG SWOT Analysis
Table 41. B.Braun Melsengen AG Drug Eluting Stents (DES) Product and Services
Table 42. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Vascular Drug Eluting Stents (DES) Major Business
Table 45. Medtronic Vascular Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 46. Medtronic Vascular SWOT Analysis
Table 47. Medtronic Vascular Drug Eluting Stents (DES) Product and Services
Table 48. Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 50. Blue Medical Drug Eluting Stents (DES) Major Business
Table 51. Blue Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 52. Blue Medical SWOT Analysis
Table 53. Blue Medical Drug Eluting Stents (DES) Product and Services
Table 54. Blue Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biotronik Basic Information, Manufacturing Base and Competitors
Table 56. Biotronik Drug Eluting Stents (DES) Major Business
Table 57. Biotronik Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 58. Biotronik SWOT Analysis
Table 59. Biotronik Drug Eluting Stents (DES) Product and Services
Table 60. Biotronik Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Essen Basic Information, Manufacturing Base and Competitors
Table 62. Essen Drug Eluting Stents (DES) Major Business
Table 63. Essen Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 64. Essen SWOT Analysis
Table 65. Essen Drug Eluting Stents (DES) Product and Services
Table 66. Essen Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 68. Relisys Medical Drug Eluting Stents (DES) Major Business
Table 69. Relisys Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 70. Relisys Medical SWOT Analysis
Table 71. Relisys Medical Drug Eluting Stents (DES) Product and Services
Table 72. Relisys Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 74. Sino Medical Drug Eluting Stents (DES) Major Business
Table 75. Sino Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 76. Sino Medical SWOT Analysis
Table 77. Sino Medical Drug Eluting Stents (DES) Product and Services
Table 78. Sino Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 80. MicroPort Medical Drug Eluting Stents (DES) Major Business
Table 81. MicroPort Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 82. MicroPort Medical SWOT Analysis
Table 83. MicroPort Medical Drug Eluting Stents (DES) Product and Services
Table 84. MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 86. Terumo Medical Drug Eluting Stents (DES) Major Business
Table 87. Terumo Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 88. Terumo Medical SWOT Analysis
Table 89. Terumo Medical Drug Eluting Stents (DES) Product and Services
Table 90. Terumo Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 92. Reva Medical Drug Eluting Stents (DES) Major Business
Table 93. Reva Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 94. Reva Medical SWOT Analysis
Table 95. Reva Medical Drug Eluting Stents (DES) Product and Services
Table 96. Reva Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 98. Promed Medical Drug Eluting Stents (DES) Major Business
Table 99. Promed Medical Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 100. Promed Medical SWOT Analysis
Table 101. Promed Medical Drug Eluting Stents (DES) Product and Services
Table 102. Promed Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. MIV Therapeutics Drug Eluting Stents (DES) Major Business
Table 105. MIV Therapeutics Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 106. MIV Therapeutics SWOT Analysis
Table 107. MIV Therapeutics Drug Eluting Stents (DES) Product and Services
Table 108. MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Sorin Drug Eluting Stents (DES) Type and Application
Table 110. Sorin Drug Eluting Stents (DES) Major Business
Table 111. Sorin Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 112. Sorin SWOT Analysis
Table 113. Sorin Drug Eluting Stents (DES) Product and Services
Table 114. Sorin Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 116. Sahajanand Drug Eluting Stents (DES) Major Business
Table 117. Sahajanand Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 118. Sahajanand SWOT Analysis
Table 119. Sahajanand Drug Eluting Stents (DES) Product and Services
Table 120. Sahajanand Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 122. Orbusneich Drug Eluting Stents (DES) Major Business
Table 123. Orbusneich Drug Eluting Stents (DES) Total Revenue (USD Million) (2017-2018)
Table 124. Orbusneich SWOT Analysis
Table 125. Orbusneich Drug Eluting Stents (DES) Product and Services
Table 126. Orbusneich Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Drug Eluting Stents (DES) Sales by Manufacturer (2018-2019) (K Units)
Table 128. Global Drug Eluting Stents (DES) Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Drug Eluting Stents (DES) Sales by Regions (2015-2020) (K Units)
Table 130. Global Drug Eluting Stents (DES) Sales Market Share by Regions (2015-2020)
Table 131. Global Drug Eluting Stents (DES) Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 133. North America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 134. North America Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 136. Europe Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 137. Europe Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 138. Europe Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Drug Eluting Stents (DES) Sales by Regions (2015-2020) (K Units)
Table 140. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Drug Eluting Stents (DES) Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 143. South America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 144. South America Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 146. Middle East& Africa Drug Eluting Stents (DES) Sales by Countries (2015-2020) (K Units)
Table 147. Middle East& Africa Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Table 148. Middle East& Africa Drug Eluting Stents (DES) Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East& Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Table 150. Global Drug Eluting Stents (DES) Sales by Type (2015-2020) (K Units)
Table 151. Global Drug Eluting Stents (DES) Sales Share by Type (2015-2020)
Table 152. Global Drug Eluting Stents (DES) Revenue by Type (2015-2020) (USD Million)
Table 153. Global Drug Eluting Stents (DES) Revenue Share by Type (2015-2020)
Table 154. Global Drug Eluting Stents (DES) Sales by Application (2015-2020) (K Units)
Table 155. Global Drug Eluting Stents (DES) Sales Share by Application (2015-2020)
Table 156. Global Drug Eluting Stents (DES) Sales Forecast by Regions (2021-2025) (K Units)
Table 157. Global Drug Eluting Stents (DES) Market Share Forecast by Regions (2021-2025)
Table 158. Global Drug Eluting Stents (DES) Sales Forecast by Type (2021-2025) (K Units)
Table 159. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2021-2025)
Table 160. Global Drug Eluting Stents (DES) Sales Forecast by Application (2021-2025)
Table 161. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros& Cons
Table 163. Indirect Channel Pros& Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drug Eluting Stents (DES) Picture
Figure 2. Global Sales Market Share of Drug Eluting Stents (DES) by Type in 2019
Figure 3. Cobalt-chromium alloy Stents Picture
Figure 4. Magnesium alloy Stents Picture
Figure 5. Tyrosine polycarbonate Stents Picture
Figure 6. Nitinol Stents Picture
Figure 7. Platinum chromium alloy Stents Picture
Figure 8. Stainless steel Stents Picture
Figure 9. Other Materials Picture
Figure 10. Drug Eluting Stents (DES) Sales Market Share by Application in 2018
Figure 11. Coronary Heart Disease Picture
Figure 12. Clinical Picture
Figure 13. Global Drug Eluting Stents (DES) Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Drug Eluting Stents (DES) Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturer in 2019
Figure 34. Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Drug Eluting Stents (DES) Revenue Market Share by Regions (2015-2020)
Figure 41. Global Drug Eluting Stents (DES) Revenue Market Share by Regions in 2018
Figure 42. North America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 43. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 45. South America Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 46. Middle East& Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020)
Figure 47. North America Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Drug Eluting Stents (DES) Sales Market Share by Countries (2015-2020)
Figure 49. North America Drug Eluting Stents (DES) Sales Market Share by Countries in 2018
Figure 50. North America Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Drug Eluting Stents (DES) Revenue Market Share by Countries in 2018
Figure 52. United States Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 58. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Drug Eluting Stents (DES) Revenue Market Share by Regions 2019
Figure 66. China Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Drug Eluting Stents (DES) Sales Market Share by Countries in 2019
Figure 73. South America Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 74. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Drug Eluting Stents (DES) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Drug Eluting Stents (DES) Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Drug Eluting Stents (DES) Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Drug Eluting Stents (DES) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 90. Middle East& Africa Sales Drug Eluting Stents (DES) Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
